February 10, 2020 - Page 12 of 15

NASDAQ Companies - February 10, 2020

vTv Therapeutics Announces Positive Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399, Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes

– TTP399, a novel glucokinase activator, achieves primary objective of a statistically significant reduction in HbA1c, without increases in hypoglycemia […]

NASDAQ Companies - February 10, 2020

Mesa Air Group Reports January 2020 Operating Performance

PHOENIX, Feb. 10, 2020 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) today reported Mesa Airlines’ operating performance for January 2020.Mesa […]

NASDAQ Companies - February 10, 2020

Immunovant to Present at the 9th Annual SVB Leerink Global Healthcare Conference

NEW YORK, Feb. 10, 2020 (GLOBE NEWSWIRE) — Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal […]

NASDAQ Companies - February 10, 2020

Nuance’s Quality Solutions Named #1 Category Leader in Best in KLAS Report

BURLINGTON, Mass., Feb. 10, 2020 (GLOBE NEWSWIRE) — Nuance Communications, Inc. (NASDAQ: NUAN) today announced it has been named the […]

NASDAQ Companies - February 10, 2020

Applied Optoelectronics Announces Availability of 25G Cooled LWDM Lasers

SUGAR LAND, Texas, Feb. 10, 2020 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (Nasdaq: AAOI), a leading provider of fiber-optic access […]

NASDAQ Companies - February 10, 2020

BrainsWay Appoints Avner Lushi to Join Board of Directors

PATTERSON, N.J., Feb. 10, 2020 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”), a commercial stage medical device […]

NASDAQ Companies - February 10, 2020

Pluristem Therapeutics CEO Issues Shareholder Update

HAIFA, Israel, Feb. 10, 2020 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a […]

NASDAQ Companies - February 10, 2020

Aquestive Therapeutics Announces U.S. Food and Drug Administration Filing Acceptance of New Drug Application (NDA) for Libervant™ (diazepam) Buccal Film

FDA Acceptance of Libervant™ (diazepam) Buccal Film NDA for Management of Seizure ClustersPotential for First Oral Diazepam-Based Therapy for Population […]

TSX Venture News - February 10, 2020

Solar Alliance Signs Agreement to Build Commercial Solar Project at Tennessee Farm

VANCOUVER, British Columbia and KNOXVILLE, Tenn., Feb. 10, 2020 (GLOBE NEWSWIRE) — Solar Alliance Energy Inc. (‘Solar Alliance’ or the […]

TSX Venture News - February 10, 2020

Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre

Investigation underway into unexpected and inconsistent findings that may have negatively impacted results reported in TRILOGY 1Announces plans to seek […]